Differential effects of cocaine and MDMA self-administration on cortical serotonin transporter availability in monkeys

Neuropharmacology

Volumn 61, Issue 1-2, 2011, Pages 245-251

  Gould, Robert W ^a   Gage, H Donald ^a   Banks, Matthew L ^a,b   Blaylock, Brandi L ^a   Czoty, Paul W ^a   Nader, Michael A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Cocaine; MDMA; Nonhuman primates; PET; Self administration; SERT

Indexed keywords

3 AMINO 4 (2 DIMETHYLAMINO METHYLPHENYLSULFANYL) BENZONITRILE C11; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; COCAINE; RADIOPHARMACEUTICAL AGENT; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; BRAIN REGION; CINGULATE GYRUS; COCAINE DEPENDENCE; COGNITION; CONTROLLED STUDY; DRUG ABUSE; DRUG SELF ADMINISTRATION; EXECUTIVE FUNCTION; EXPERIMENTAL MONKEY; HIPPOCAMPUS; IMAGE ANALYSIS; MALE; NONHUMAN; OCCIPITAL CORTEX; PARIETAL CORTEX; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN METABOLISM; TEMPORAL CORTEX; THALAMUS; TISSUE DISTRIBUTION;

ANIMALS; CEREBRAL CORTEX; COCAINE; HAPLORHINI; MACACA MULATTA; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; POSITRON-EMISSION TOMOGRAPHY; SELF ADMINISTRATION; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 79957850185     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.04.007     Document Type: Article

References (75)

1. Ali, S.F., Newport, G.D., Scallet, A.C., Binienda, Z., Ferguson, S.A., Bailey, J.R., Paule, M.G., Slikker, W., 1993. Oral administration of 3,4-Methylenedioxymethamphetamine (MDMA) produces selective serotonergic depletion in the nonhuman primate. Neurotoxicol. Teratol. 15, 91-96.
2. Banks, M.L., Czoty, P.W., Gage, H.D., Bounds, M.C., Garg, P.K., Garg, S., Nader, M.A., 2008. Effects of cocaine and MDMA self-administration on serotonin transporter availability in monkeys. Neuropsychopharmacology 33, 219-225. (Pubitemid 350243361)
3. Battaglia, G., Brooks, B.P., Kulsakdinun, C., De Souza, E.B., 1988. Pharmacologic profile of MDMA (3,4-methylendioxymethamphetamine) at various brain recognition sites. Eur. J. Pharmacol. 149, 159-163.
4. Battaglia, G., Sharkey, J., Kuhar, M.J., De Souza, E.B., 1991. Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4-methylenedioxymethamphetamine): assessment using quantitative autoradiography. Synapse 8, 249-260.
5. 3H]- paroxetine-labelled serotonin uptake sites. J. Pharmacol. Exp. Ther. 242, 911-916.
6. Bennett, B.A., Wichems, C.H., Hollingsworth, C.K., Davies, H.M., Thornley, C., Sexton, T., et al., 1995. Novel 2-substituted cocaine analogs: uptake and ligand binding studies of dopamine, serotonin, and norepinephrine transport sites in the rat brain. J. Pharmacol. Exp. Ther. 272, 1176-1186.
7. Biezonski, D.K., Meyer, J.S., 2010. Effects of 3,4,- methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity. J. Neurochem. 112, 951-962.
8. Bozkurt, A., Zilles, K., Schleicher, A., Kamper, L., Arigita, E.S., Uylings, H.B.M., Kotter, R., 2005. Distributions of transmitter receptors in the macaque cingulate cortex. Neuroimage 25, 219-229. (Pubitemid 40292053)
9. Browne, J., McKone, E., Ward, J., 2010. Deficits of long-term memory in ecstasy users are related to cognitive complexity of the task. Psychopharmacology 209, 51-67.
10. 11C](+)McN5652-PET and the multilinear reference tissue model: loss of transporters or artifact of tracer kinetic modelling? J. Psychopharm. 21, 628-634.
11. Buchert, R., Thomasius, R., Nebeling, B., Petersen, K., Obrocki, J., Jenicke, L., Wilke, F., Wartberg, L., Zapletalova, P., Clausen, M., 2003. Long-term effects of "ecstasy" use on serotonin transporters of the brain investigated by PET. J. Nucl. Med. 44, 375-384.
12. Buchert, R., Thomasius, R., Petersen, K., Wilke, F., Obrocki, J., Nebeling, B., Wartberg, L., Zapletalova, P., Clausen, M., 2006. Reversibility of ecstasy-induced reductions in serotonin transporter availability in polydrug ecstasy users. Eur. J. Nucl. Med. Mol. Imaging 33, 188-199.
13. Buchert, R., Thomasius, R., Wilke, F., Petersen, K., Nebeling, B., Obrocki, J., Schulze, O., Schmidt, U., Clausen, M., 2004. A voxel-based PET investigation of the long-term effects of "ecstasy" consumption on brain serotonin transporters. Am. J. Psychiatry 161, 1181-1189.
14. Colzato, L., Huizinga, M., Hommel, B., 2009. Recreational cocaine polydrug use impairs cognitive flexibility but not working memory. Psychopharmacology 207, 225-234.
15. Cunningham, K.A., Paris, J.M., Goeders, N.E., 1992. Chronic cocaine enhances serotonin autoregulation and serotonin uptake binding. Synapse 11, 112-123.
16. Devinsky, O., Morrell, M.J., Vogt, B.A., 1995. Contributions of anterior cingulate cortex to behaviour. Brain. 118, 279-306.
17. Dias, R., Robbins, T.W., Roberts, A.C., 1996a. Dissociation in prefrontal cortex of affective and attentional shifts. Nature 380, 69-72. (Pubitemid 26076238)
18. Dias, R., Robbins, T.W., Roberts, A.C., 1996b. Primate analogue of the Wisconsin Card Sorting Task: effects of excitotoxic lesions in the prefrontal cortex in the marmoset. Behav. Neurosci. 110, 872-876.
19. Dias, R., Robbins, T.W., Roberts, A.C., 1997. Dissociable forms of inhibitory control within prefrontal cortex with an analog of the Wisconsin Card Sort Test: Restriction to novel situations and independence from "On-Line" processing. J. Neurosci. 17, 9285-9297.
20. Everitt, B.J., Robbins, T.W., 2005. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat. Neurosci. 8, 1481-1489.
21. Elfving, B., Madsen, J., Knudsen, G.M., 2007. Neuroimaging of the serotonin reuptake site requires high-affinity ligands. Synapse 61, 882-888. (Pubitemid 47464084)
22. Ersche, K.D., Rosier, J.P., Robbins, T.W., Sahakian, B.J., 2008. Chronic cocaine but not chronic amphetamine use is associated with perseverative responding in humans. Psychopharmacology 197, 421-431.
23. Fantegrossi, W.E., Bauzo, R.M., Manvich, D.M., Morales, J.C., Votaw, J.R., Goodman, M.M., Howell, L.L., 2009. Role of the dopamine transporters in the behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in nonhuman primates. Psychopharmacology 205, 337-347.
24. Fantegrossi, W.E., Woolverton, W.L., Kilbourn, M., Sherman, P., Yuan, J., Hatzidimitriou, G., Ricaurte, G.A., Woods, J.H., Winger, G., 2004. Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys. Neuropsychopharmacology 29, 1270-1281. (Pubitemid 38780650)
25. Fernandez-Serrano, M.J., Perez-Garcia, M., Verdejo-Garcia, A., 2010. What are the specific vs generalized effects of drugs of abuse on neuropsychological performance? Neurosci. Biobehav. Rev. 35, 377-406.
26. Fillmore, M.T., Rush, C.R., 2002. Impaired inhibitory control of behavior in chronic cocaine users. Drug Alcohol Depen. 66, 265-273. (Pubitemid 34327862)
27. Fillmore, M.T., Rush, C.R., Hays, L., 2005. Cocaine improves inhibitory control in human model of response conflict. Exp. Clin. Psychopharmacol. 13, 327-335.
28. Fillmore, M.T., Rush, C.R., Hays, L., 2006. Acute effects of cocaine in two models of inhibitory control: implications of non-linear dose effects. Addiction 101, 1323-1332. (Pubitemid 44199524)
29. Goldstein, R.Z., Volkow, N.D., 2002. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am. J. Psychiatry 159, 1642-1652.
30. Goldstein, R.Z., Tomasi, D., Rajaram, S., Cottone, L.A., Zhang, L., Maloney, T., et al., 2007. Role of the anterior cingulate and medial orbitofrontal cortex in processing drug cues in cocaine addiction. Neuroscience 144, 1153-1159. (Pubitemid 46123821)
31. Green, A.R., Mechan, A.O., Elliott, J.M., O'Shea, E., Colado, M.I., 2003. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol. Rev. 55, 463-508. (Pubitemid 37013213)
32. Gudelsky, G.A., Yamamoto, B.K., 2008. Actions of 3,4- methylendioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic, and cholinergic neurons. Pharmacol. Biochem. Behav. 90, 198-207.
33. Harvey, R.C., Dembro, K.A., Rajagopalan, K., Mutebi, M.M., Kantak, K.M., 2009. Effects of self-administered cocaine in adolescent and adult male rats on orbitofrontal cortex-related neurocognitive functioning. Psychopharmacology 206, 61-71.
34. Hester, R., Garavan, H., 2004. Executive dysfunction in cocaine addiction: evidence for discordant frontal, cingulate, and cerebellar activity. J. Neurosci. 24, 11017-11022. (Pubitemid 40012960)
35. Hopper, J.W., Su, Z., Looby, A.R., Ryan, E.T., Penetar, D.M., Palmer, C.M., Lukas, S.E., 2006. Incidence and patterns of polydrug use and craving for ecstasy in regular ecstasy users: an ecological momentary assessment study. Drug Alcohol Depen. 85, 221-235. (Pubitemid 44666280)
36. Insel, T.R., Battaglia, G., Johannessen, J.N., Marra, S., De Souza, E.B., 1989. 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys. J. Pharmacol. Exp. Ther. 249, 713-720.
37. Jacobsen, L.K., Staley, J.K., Malison, R.T., Zoghbi, S.S., Seibyl, J.P., Kosten, T.R., Innis, R.B., 2000. Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patients. Am. J. Psychiatry 157, 1134-1140. (Pubitemid 30432496)
38. Kaufman, J.N., Ross, T.J., Stein, E.A., Garavan, H., 2003. Cingulate hypoactivity in cocaine users during a GO-NOGO task as revealed be event-related functional magnetic resonance imaging. J. Neurosci. 23, 7839-7843. (Pubitemid 37052351)
39. 11)C]DASB and structural brain imaging study. Brain 133, 1779-1797.
40. Kittler, K., Lau, T., Schloss, P., 2010. Antagonists and substrates differentially regulate serotonin transporter cell surface expression in serotonergic neurons. Eur. J. Pharmacol. 629, 63-67.
41. Kivell, B., Day, D., Bosch, P., Schenk, S., Miller, J., 2010. MDMA causes a redistribution of serotonin transporter from the cell surface to the intracellular compartment by a mechanism independent of phospho-p38-mitogen activated protein kinase activation. Neuroscience 168, 82-95.
42. Kubler, A., Murphy, K., Garavan, H., 2005. Cocaine dependence and attention switching within and between verbal and visuospatial working memory. Eur. J. Neurosci. 21, 1984-1992.
43. Letchworth, S.R., Nader, M.A., Smith, H.R., Friedman, D.P., Porrino, L.J., 2001. Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys. J. Neurosci. 21, 2799-2807. (Pubitemid 32298221)
44. Li, I.H., Huang, W.S., Shiue, C.Y., Huang, Y.Y., Liu, R.S., Chyeuh, S.C., et al., 2010. Study on the neuroprotective effect of fluoxetine against MDMA-induced neurotoxicity on the serotonin transporter in rat brain using micro-PET. Neuroimage 49, 1259-1270.
45. Lile, J.A., Ross, J.T., Nader, M.A., 2005. A comparison of the reinforcing efficacy of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") with cocaine in rhesus monkeys. Drug Alcohol Depend. 78, 135-140. (Pubitemid 40544600)
46. 3H]WIN 35428 binding sites in human striatum. Brain Res. 628, 17-25.
47. Logan, J., Fowler, J.S., Wolkow, N.D., Wang, G.J., Ding, Y.S., Alexoff, D.L., 1996. Distribution volume ratios without blood sampling from graphical analysis of PET data. J. Cereb. Blood Flow Metab. 16, 834-840.
48. Mash, D.C., Staley, J.K., Izenwasser, S., Basile, M., Ruttenber, A.J., 2000. Serotonin transporters upregulate with chronic cocaine use. J. Chem. Neuroanat. 20, 271-280.
49. McCann, U.D., Szabo, Z., Scheffel, U., Dannals, R.F., Ricaurte, G.A., 1998. Positron emission tomographic evidence of toxic effect of MDMA ("ecstasy") on brain serotonin neurons in human beings. Lancet 352, 1433-1437. (Pubitemid 28510877)
50. 11C]DASB. Neuropsychopharmacology 30, 1741-1750.
51. McCann, U.D., Szabo, Z., Vranesic, M., Palermo, M., Mathews, W.B., Ravert, H.T., Dannals, R.F., Ricaurte, G.A., 2008. Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (±)3,4-methlenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance. Psychopharmacology 200, 439-450.
52. Nader, M.A., Morgan, D., Gage, H.D., Nader, S.H., Calhoun, T.L., Buchheimer, N., Ehrenkaufer, R., Mach, R.H., 2006. PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys. Nat. Neurosci. 9, 1050-1056.
53. O'Brien, C.P., 2008. Evidence-based treatments of addiction. Philos. Trans. R. Soc. Lond., B, Biol. Sci. 363, 3277-3286.
54. O'Shea, E., Granados, R., Esteban, B., Colado, M.I., Green, A.R., 1998. The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy'). Neuropharmacology 37, 919-926. (Pubitemid 28375758)
55. Palomero-Gallagher, N., Vogt, B.A., Schleicher, A., Mayberg, H.S., Zilles, K., 2009. Receptor architecture of human cingulate cortex: evaluation of the four-region neurobiological model. Hum. Brain Map. 30, 2336-2355.
56. Parrott, A.C., Lasky, J., 1998. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance. Psychopharmacol. 139, 261-268. (Pubitemid 28439526)
57. Parrott, A.C., Lees, A., Garnham, N.J., Jones, M., Wesnes, K., 1998. Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits. J. Psychopharmacol. 12, 79-83.
58. Roberts, G.M.P., Garavan, H., 2010. Evidence of increased activation underlying cognitive control in ecstasy and cannabis users. Neuroimage 52, 429-435.
59. Sarkar, S., Schmued, L., 2010. Neurotoxicity of ecstasy (MDMA): an overview. Curr. Pharm. Biotechnol. 11, 460-469.
60. Scanzello, C.R., Hatzidimitriou, G., Martello, A.L., Katz, J.L., Ricaurte, G.A., 1993. Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine injury: observations in rats. J. Pharmacol. Exp. Ther. 264, 1484-1491.
61. Scheffel, U., Szabo, Z., Mathews, W.B., Finley, P.A., Dannals, R.F., Ravert, H.T., Szabo, K., Yuan, J., Ricaurte, G.A., 1998. In vivo detection of short- and long-term MDMA neurotoxicity e a positron emission tomography study in the living baboon brain. Synapse 29, 183-192.
62. Schenk, S., 2009. MDMA self-administration in laboratory animals: a summary of the literature and proposal for future research. Neuropsychobiology 60, 130-136.
63. Schenk, S., Harper, DN., Do, J. Novel object recognition memory: measurement issues and effects of MDMA self-administration following short inter-trial intervals. J. Psychopharmacol. in press (online at http://jop.sagepub.com/content/early/2010/12/02/0269881110389213).
64. Schenk, S., Hely, L., Lake, B., Daniela, E., Gittings, D., Mash, D.C., 2007. MDMA self-administration in rats: acquisition, progressive ratio responding and serotonin transporter binding. Eur. J. Neurosci. 26, 3229-3236.
65. Selvaraj, S., Hoshi, R., Bhagwagar, Z., Murthy, N.V., Hinz, R., Cowen, P., Curran, H.V., Grasby, P., 2009. Brain serotonin transporter binding in former users of MDMA ('ecstasy'). Br. J. Psychiatry 194, 355-359.
66. Sprague, J.E., Everman, S.L., Nichols, D.E., 1998. An integrated hypothesis for the serotonergic axonal loss induced by 3,4,- methylenedioxymethamphetamine. Neurotoxicology 19, 427-431.
67. 3H]monoamines into synaptosomes from different regions of rat brain. Biochem. Pharmacol. 36, 2297-2303.
68. 11C-DASB as serotonin transporter radioligands under various experimental conditions. J. Nucl. Med. 43, 678-692.
69. Turner, T.H., LaRowe, S., Horner, M.D., Herron, J., Malcolm, R., 2009. Measures of cognitive functioning as predictors of treatment outcome for cocaine dependence. J. Subst. Abuse Treat. 37, 328-334.
70. Verrico, C.D., Lynch, L., Fahey, M.A., Fryer, A.K., Miller, G.M., Madras, B.K., 2008. MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor. J. Psychopharmacol. 22, 187-202. (Pubitemid 351322857)
71. Vogt, B.A., 2005. Pain and emotion interactions in subregions of the cingulate gyrus. Nat. Rev. Neurosci. 6, 533-544.
72. Volkow, N.D., Fowler, J.S., 2000. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb. Cort. 10, 318-325.
73. Volkow, N.D., Fowler, J.S., Wang, G.-J., Hitzemann, R., Logan, J., Schyler, D.J., Dewey, S.L., Wolf, A.P., 1993. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14, 169-177. (Pubitemid 23157765)
74. Vollenweider, F.X., Gamma, A., Liechti, M., Huber, T., 1998. Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naive healthy volunteers. Neuropsychopharmacology 19, 241-251. (Pubitemid 28491334)
75. Yu, C., Zhou, Y., Liu, Y., Jiang, T., Dong, H., Zhang, Y., Walter, M., 2011. Functional segregation of the human cingulate cortex is confirmed by functional connectivity based neuroanatomical parcellation. Neuroimage. 54, 2571-2581.